Research output per year
Research output per year
Fingerprint
Dive into the research topics where Angela Corpolongo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022
Antinori, A., Mazzotta, V., Vita, S., Carletti, F., Tacconi, D., Lapini, L. E., D’Abramo, A., Cicalini, S., Lapa, D., Pittalis, S., Puro, V., Capparuccia, M. R., Giombini, E., Gruber, C. E. M., Garbuglia, A. R., Marani, A., Vairo, F., Girardi, E., Vaia, F., Nicastri, E., & 40 others, 2022, In: Eurosurveillance. 27, 2, p. 1-6 6 p.Research output: Contribution to journal › Article › peer-review
-
Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
INMI COVID-19 Vaccine Study Group, Feb 2022, In: Neurology. 98, 5, p. e541-e554 14 p.Research output: Contribution to journal › Article › peer-review
-
Infectious Toscana Virus in Seminal Fluid of Young Man Returning from Elba Island, Italy
Matusali, G., D'Abramo, A., Terrosi, C., Carletti, F., Colavita, F., Vairo, F., Savellini, G. G., Gandolfo, C., Anichini, G., Lalle, E., Bordi, L., Corpolongo, A., Maritti, M., Marchioni, L., Capobianchi, M. R., Castilletti, C., Cusi, M. G. & Nicastri, E., Apr 2022, In: Emerging Infectious Diseases. 28, 4, p. 865-869 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
the INMI COVID-19 Vaccine Study Group, Feb 28 2022, In: Frontiers in Immunology. 13, p. 1-16 16 p., 846753.Research output: Contribution to journal › Article › peer-review
Open Access -
Molecular Characterization of Whole-Genome SARS-CoV-2 from the First Suspected Cases of the XE Variant in the Lazio Region, Italy
SARS CoV-2 Lazio Surveillance Study Group, Sept 2022, In: Diagnostics. 12, 9, p. 1-11 11 p., 2219.Research output: Contribution to journal › Article › peer-review
Open Access